PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 111 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2016. The put-call ratio across all filers is 2.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $573,000 | -50.8% | 19,237 | -51.4% | 0.00% | -62.5% |
| Q1 2016 | $1,164,000 | -56.9% | 39,619 | +15.0% | 0.01% | -61.9% |
| Q4 2015 | $2,701,000 | +7.3% | 34,456 | +3.1% | 0.02% | +10.5% |
| Q3 2015 | $2,518,000 | -57.0% | 33,409 | -33.3% | 0.02% | -45.7% |
| Q2 2015 | $5,852,000 | -49.7% | 50,125 | +1.8% | 0.04% | -47.8% |
| Q1 2015 | $11,630,000 | +10.0% | 49,258 | -11.8% | 0.07% | +1.5% |
| Q4 2014 | $10,575,000 | -12.0% | 55,875 | +11.0% | 0.07% | +3.1% |
| Q3 2014 | $12,014,000 | – | 50,360 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |